Somatostatin group (n = 135) | Placebo group (n = 135) | p Value | |
---|---|---|---|
Values are number (%). | |||
CBD, common bile duct. | |||
*All patients had at least one therapeutic procedure; some patients had more than one procedure. | |||
†Required more than three attempts at cannulation. | |||
‡CBD <8 mm. | |||
Therapeutic procedure* | |||
Biliary sphincterotomy | 98 (72.6%) | 92 (68.1%) | 0.424 |
Precut | 6 (4.4%) | 5 (3.7%) | 0.758 |
Biliary stenting | 47 (34.8%) | 54 (40.0%) | 0.379 |
CBD stone extraction | 62 (45.9%) | 51 (37.8%) | 0.175 |
Balloon dilation of sphincter of Oddi | 7 (5.2%) | 6 (4.4%) | 0.776 |
Difficult cannulation† | 58 (43.0%) | 56 (41.5%) | 0.805 |
Non-dilated CBD | 44 (32.6%) | 46 (34.1%) | 0.796 |
Pancreatic duct cannulation | 38 (28.1%) | 42 (31.1%) | 0.594 |
Repeated (⩾3 times) pancreatic injection | 7 (5.2%) | 6 (4.4%) | 0.776 |
Pancreatic acinarisation | 3 (2.2%) | 4 (3.0%) | 1.000 |